SHL Telemedicine Return On Tangible Equity 2022-2024 | SHLT

SHL Telemedicine return on tangible equity from 2022 to 2024. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.

SHL Telemedicine Return On Tangible Equity 2022-2024 | SHLT

SHL Telemedicine return on tangible equity from 2022 to 2024. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Related Stocks
Company NameMarket
Cap
Tempus AI (TEM)$9.2B
Inspire Medical Systems (INSP)$5.7B
Hims & Hers Health (HIMS)$5.5B
Enovis (ENOV)$2.6B
Privia Health (PRVA)$2.6B
IRhythm Technologies (IRTC)$2.3B
Azenta (AZTA)$2.2B
Omnicell (OMCL)$2.1B
10x Genomics (TXG)$1.7B
Clover Health Investments (CLOV)$1.7B
Schrodinger (SDGR)$1.5B
Phreesia (PHR)$1.1B
Butterfly Network (BFLY)$690M
Standard BioTools (LAB)$596M
Talkspace (TALK)$583M
Fulgent Genetics (FLGT)$547M
Definitive Healthcare (DH)$505M
Health Catalyst (HCAT)$495M
Pulmonx (LUNG)$268M
TruBridge (TBRG)$247M
SOPHiA GENETICS SA (SOPH)$209M
American Well (AMWL)$124M
EUDA Health Holdings (EUDA)$112M
P3 Health Partners (PIII)$76M
HeartBeam (BEAT)$74M
111 (YI)$52M
CareCloud (CCLD)$46M
Outset Medical (OM)$44M
Zepp Health (ZEPP)$37M
Movano (MOVE)$23M